DE69125161T3 - Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper - Google Patents

Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper

Info

Publication number
DE69125161T3
DE69125161T3 DE69125161T DE69125161T DE69125161T3 DE 69125161 T3 DE69125161 T3 DE 69125161T3 DE 69125161 T DE69125161 T DE 69125161T DE 69125161 T DE69125161 T DE 69125161T DE 69125161 T3 DE69125161 T3 DE 69125161T3
Authority
DE
Germany
Prior art keywords
mixtures
antibodies against
synthetic peptides
against hiv
detecting antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69125161T
Other languages
English (en)
Other versions
DE69125161T2 (de
DE69125161D1 (de
Inventor
Martial Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaltis Inc
Original Assignee
Adaltis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24195143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69125161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adaltis Inc filed Critical Adaltis Inc
Application granted granted Critical
Publication of DE69125161D1 publication Critical patent/DE69125161D1/de
Publication of DE69125161T2 publication Critical patent/DE69125161T2/de
Publication of DE69125161T3 publication Critical patent/DE69125161T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69125161T 1990-07-09 1991-07-08 Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper Expired - Fee Related DE69125161T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/549,964 US5241047A (en) 1988-12-08 1990-07-09 Synthetic peptides and mixtures thereof for detecting HIV antibodies
PCT/CA1991/000233 WO1992000997A1 (en) 1990-07-09 1991-07-08 Synthetic peptides and mixtures thereof for detecting hiv antibodies

Publications (3)

Publication Number Publication Date
DE69125161D1 DE69125161D1 (de) 1997-04-17
DE69125161T2 DE69125161T2 (de) 1997-06-19
DE69125161T3 true DE69125161T3 (de) 2002-03-07

Family

ID=24195143

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125161T Expired - Fee Related DE69125161T3 (de) 1990-07-09 1991-07-08 Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper

Country Status (17)

Country Link
US (1) US5241047A (de)
EP (1) EP0538283B2 (de)
JP (1) JP3533214B2 (de)
AP (1) AP9100291A0 (de)
AT (1) ATE150031T1 (de)
AU (1) AU664828B2 (de)
CA (1) CA2086922C (de)
CS (1) CS209691A3 (de)
DE (1) DE69125161T3 (de)
ES (1) ES2098359T5 (de)
IE (1) IE912377A1 (de)
IL (1) IL98769A (de)
MX (1) MX9100115A (de)
NZ (1) NZ238856A (de)
PT (1) PT98249B (de)
WO (1) WO1992000997A1 (de)
ZA (1) ZA915286B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210874B1 (en) * 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6518013B1 (en) 1993-06-07 2003-02-11 Trimeris, Inc. Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
EP0698214A1 (de) * 1994-03-02 1996-02-28 Abbott Laboratories Hiv immunoassay unter verwendung rekombinanter proteine und synthetischer peptidreagenzien
AU2790899A (en) * 1998-03-04 1999-09-20 Universal Health-Watch, Inc. Rapid confirmatory test for microbial infections
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
AU2005265182B2 (en) * 2004-06-17 2012-06-21 Mannkind Corporation Epitope analogs
EP2309269B1 (de) 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion
WO2007084021A2 (en) * 2006-01-17 2007-07-26 Instituto De Medicina Molecular Compositions and methods for diagnosing hiv-2 infection
JP6906547B2 (ja) * 2016-12-09 2021-07-21 富士フイルム株式会社 ミックスモードアフィニティクロマトグラフィー用担体
CN109374884B (zh) * 2018-12-24 2021-10-22 四川沃文特生物技术有限公司 一种pct浓度检测试剂盒及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
EP0247557B1 (de) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV)Decke-Peptide
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern

Also Published As

Publication number Publication date
CA2086922A1 (en) 1992-01-10
ES2098359T3 (es) 1997-05-01
IE912377A1 (en) 1992-01-15
DE69125161T2 (de) 1997-06-19
EP0538283B1 (de) 1997-03-12
CA2086922C (en) 2003-01-14
NZ238856A (en) 1992-12-23
CS209691A3 (en) 1992-03-18
EP0538283A1 (de) 1993-04-28
JPH05508837A (ja) 1993-12-09
JP3533214B2 (ja) 2004-05-31
IL98769A (en) 1997-11-20
MX9100115A (es) 1992-02-28
PT98249A (pt) 1992-05-29
WO1992000997A1 (en) 1992-01-23
ES2098359T5 (es) 2001-10-16
ZA915286B (en) 1993-03-31
AP9100291A0 (en) 1993-01-09
US5241047A (en) 1993-08-31
AU664828B2 (en) 1995-12-07
PT98249B (pt) 1998-12-31
ATE150031T1 (de) 1997-03-15
EP0538283B2 (de) 2001-08-01
DE69125161D1 (de) 1997-04-17
IL98769A0 (en) 1992-07-15
AU8189591A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
DE69006306D1 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
DE69332485T2 (de) Immunmodulierende peptide
DE59408526D1 (de) Sensor zum nachweis von stickoxid
DK0643022T3 (da) Cementmateriale
DE69532475D1 (de) Krebs hemmende peptide
DE69033720T2 (de) Thermoplastische Materialien und hieraus hergestellte Artikel
DE69529700T2 (de) Neue Klasse von hochenergetischen Detektionsmaterialien
DE69125161T3 (de) Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper
FI903892A0 (fi) Laite materiaalisekoitusten käsittelemiseksi
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
DE59710051D1 (de) Einrichtung zum vakuumbeschichten von schüttgut
DE69330664T2 (de) Lösungsmittel zum reinigen und trocknen
DE59305849D1 (de) Planarer Sensor aus Keramikmaterial zum Nachweis von brennbaren Gasen
DK286790A (da) Overtrukne tekstilmaterialer
DE69110891D1 (de) Peptide und analoge und mischungen davon zum nachweis der gegen die viren htlv-1 und htlv-ii gerichteten antikörper.
DE69325943T2 (de) Synthetische Polypeptide vom Hepatitis C-Virus, verwendbar für den Nachweis des Virus
FI943418A (fi) Synteettiset peptidit vihurirokkorokotetta varten
DE69427363T2 (de) Plättchenaggregationsinhibierende peptide
DE69430180T2 (de) Textilmaterialienbehandlungsmittel
DE69323591D1 (de) Zusammensetzung zum Nachweis von Peroxid-aktivem Material
ZA915288B (en) Peptides and analogues and mixtures thereof for detecting antibodies to htlv-1 and htlv-11 virusses
ZA89266B (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
FI964443A (fi) Uudet ominaisuuksiltaan samanaikaisesti myy-agonistiset ja delta-antagonistiset opioidipeptidianalogit
KR960005932U (ko) 현탁액형 주입재의 침투성 및 재료분리성 측정장치
ATA221089A (de) Sackgewebe

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: ADALTIS INC., MONTREAL, QUEBEC, CH

8339 Ceased/non-payment of the annual fee